Second generation antipsychotics in ‘real-life’ paediatric patients. Adverse drug reactions and clinical outcomes of drug switchConcetta Rafaniello, Annalisa Capuano, Carla Carnovale et al.|Expert Opinion on Drug Safety|2016Cited by 33
Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settingsMarco Pozzi, Emilio Clementi, Dario Cattaneo et al.|European Journal of Clinical Pharmacology|2015Cited by 30
Persistence in Therapy With Risperidone and Aripiprazole in Pediatric OutpatientsMarco Pozzi, Carmela Bravaccio, Simone Pisano et al.|The Journal of Clinical Psychiatry|2016Cited by 17